GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
73 hedge funds and large institutions have $40.7M invested in GALENA BIOPHARMA INC COM in 2013 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 5 closing their positions.
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
183% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 12
39% more capital invested
Capital invested by funds: $29.3M → $40.7M (+$11.4M)
29% more call options, than puts
Call options by funds: $4.13M | Put options by funds: $3.2M
22% more funds holding
Funds holding: 60 → 73 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.98M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$1.82M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.8M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.71M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$957K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$800K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$771K |
| 4 |
Goldman Sachs
New York
|
-$495K |
| 5 |
JP Morgan Chase
New York
|
-$164K |
RXII Hedge Fund Activity: Q3 2013 in Review
73 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q3 2013, worth a combined $40.7M — up 39% from $29.3M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new RXII positions and 5 closed out — a net gain of 13 holders — while 34 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $1.98M. The largest seller was Morgan Stanley, cutting an estimated $957K.
- 73 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q3 2013, up from 60 in Q2 2013.
- Funds reported $40.7M of GALENA BIOPHARMA INC COM stock for Q3 2013, up 39% quarter-over-quarter.
- 18 funds opened new GALENA BIOPHARMA INC COM positions in Q3 2013 and 5 closed out, a net change of +13 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q3 2013 was BlackRock Institutional Trust, an estimated $1.98M added.
- The largest GALENA BIOPHARMA INC COM seller in Q3 2013 was Morgan Stanley, an estimated $957K sold.
Based on aggregated 13F filings for Q3 2013.